Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting necroptosis in anticancer therapy: mechanisms and modulators
Ying Wu, Guoqiang Dong, Chunquan Sheng
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 9, pp. 1601-1618
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Bioactive inorganic nanomaterials for cancer theranostics
Zifan Pei, Huali Lei, Liang Cheng
Chemical Society Reviews (2023) Vol. 52, Iss. 6, pp. 2031-2081
Closed Access | Times Cited: 125
Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine
Xuan Wang, Peng Hua, Chengwei He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3567-3593
Open Access | Times Cited: 83
RIPK3 signaling and its role in regulated cell death and diseases
Yaqi Zhou, Yaxuan Xiang, S. Liu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
Xi‐min Hu, Zhixin Li, Ruihan Lin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 95
The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications
Sheng‐Kai Hsu, Wen‐Tsan Chang, I‐Ling Lin, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2185-2185
Open Access | Times Cited: 77
Exosome‐transmitted miR‐769‐5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53
Xinming Jing, Mengyan Xie, Kun Ding, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 48
Current evidence and therapeutic implication of PANoptosis in cancer
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 33
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Necroptosis signaling and mitochondrial dysfunction cross-talking facilitate cell death mediated by chelerythrine in glioma
Peng Wang, Shiyi Zheng, Ruo-Lin Jiang, et al.
Free Radical Biology and Medicine (2023) Vol. 202, pp. 76-96
Closed Access | Times Cited: 24
Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death
Tengyu He, Jing Wen, Wenjian Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 14
Emerging role of immunogenic cell death in cancer immunotherapy
Kei‐ichiro Arimoto, Sayuri Miyauchi, Mengdan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Erythronecroptosis: an overview of necroptosis or programmed necrosis in red blood cells
Anton Tkachenko, Ondřej Havránek
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3273-3291
Closed Access | Times Cited: 10
SBFI26 induces triple‐negative breast cancer cells ferroptosis via lipid peroxidation
Gang He, Yiyuan Zhang, Yanjiao Feng, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 9
Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
Jing Zhu, Meng Xin, Congcong Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3193-3205
Open Access | Times Cited: 42
Targeting necroptosis as an alternative strategy in tumor treatment: From drugs to nanoparticles
Xinlong Zang, Jinxiao Song, Yanfeng Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 213-226
Closed Access | Times Cited: 37
Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer
Xiaojie Liu, Lu Liu, Xu Wang, et al.
Phytomedicine (2023) Vol. 118, pp. 154943-154943
Closed Access | Times Cited: 18
Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review
Leonardo de Oliveira Siquara da Rocha, Éverton Freitas de Morais, Lilianny Querino Rocha de Oliveira, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 103-103
Open Access | Times Cited: 7
Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products
Kailin Yang, Liuting Zeng, Qi He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
The central role of a two‐way positive feedback pathway in molecular targeted therapies‐mediated pyroptosis in anaplastic thyroid cancer
Qiwu Zhao, Haoran Feng, Zheyu Yang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 27
Ag/Au Bimetallic Nanoparticles Trigger Different Cell Death Pathways and Affect Damage Associated Molecular Pattern Release in Human Cell Lines
Hector Katifelis, Maria-Paraskevi Nikou, Iuliia Mukha, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1546-1546
Open Access | Times Cited: 25
Anticancer properties of complexes derived from bidentate ligands
David Izuchukwu Ugwu, Jeanet Conradie
Journal of Inorganic Biochemistry (2023) Vol. 246, pp. 112268-112268
Open Access | Times Cited: 15
Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects
Haoyu Yang, Jun Sun, Aru Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117140-117140
Closed Access | Times Cited: 5
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Wenli Zhao, Yue Liu, Lijuan Xu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 12, pp. 1697-1713
Closed Access | Times Cited: 19
Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis
Wei Yang, Shuaibing Lu, Liangqun Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia
Dake Wen, Ru Yan, Lin Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top